ARGX: argenx SE Company Short-Term Debt
argenx SE maintains an impeccable reputation in the therapy of rare autoimmune pathologies. High barriers to entry and patent protection guarantee the company long-term dominance, while the global rollout of its drugs ensures rapid profit growth. Current financial debt confirms these fundamental positions, with the indicator standing at 0.08, reflecting the dynamics of the issuer's credit load.
Metric breakdowns and analytics for argenx BVBA (ARGX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
- net income and valuation multiples indicators:
Initial company analysis:ARGX - argenx
Short-term debts reflect the total volume of financial obligations due within the next twelve months. The dynamics of these liabilities allow for an assessment of current liquidity and default risk during temporary cash shortages. Analyzing short-term liabilities helps determine the issuer's dependence on external refinancing. For argenx SE (ARGX), this indicator is critical for controlling cash burn. Payment stability correlates directly with the commercial efficiency of the drug Vyvgart.
Competitor analysis
BNTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Short-Term Debt|Company Current Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Short-Term Debts|Company Short-Term Debts kiniksa.com|Company Current Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CLDX (Celldex)|Short-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Short-Term Debt|veratx.com (VERA) - Company Current Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|Company Current Liabilities ABCL|Company Short-Term Debts Tourmaline|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|Zenas Biopharma, Inc. - Company Short-Term Debts|IMNM - Company Short-Term Debts|Gossamer Bio, Inc. (GOSS) - Company Short-Term Debt|kalvista.com - Company Short-Term Loans and Borrowings|SEPN (Septerna) - Company Short-Term Debts|PVLA - Short-Term Indebtedness|Company Short-Term Debts SVRA|RIGL - Short-Term Debt|Company Short-Term Debt AnaptysBio, Inc. ANAB|ATXS: Company Short-Term Indebtedness|ENGN: Company Current Liabilities|RAPT (rapt.com) - Company Short-Term Indebtedness|JBIO (aerovatetx.com) - Company Current Liabilities|Aclaris Therapeutics, Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt Kyverna Therapeutics|tizianalifesciences.com (TLSA) - Short-Term Debt Volume|Company Short-Term Debts CABA|VTYX - Short-Term Debt|Company Short-Term Debts THTX (Theratechnologies Inc)|Company Short-Term Debts Avalo Therapeutics Inc AVTX|ELDN - Company Short-Term Debt|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|CLYM: Company Short-Term Debts|Short-Term Indebtedness zurabio.com ZURA|Company Current Liabilities ATYR|Company Short-Term Indebtedness ADAG (Adagene Corp)|Company Short-Term Debt ImageneBio Inc (IMA)|STTK: Current Liabilities|Company Short-Term Debts EQ (Equillium)|Company Short-Term Loans and Borrowings CNTB|Immunic Inc - Company Short-Term Debts|ATRA - Company Short-Term Debts|inflarx.de (IFRX) - Company Short-Term Debt|x4pharma.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Adicet Bio Inc.|Company Current Liabilities Celularity Corp (CELU)|Company Short-Term Debts INMB|Company Short-Term Debts Barinthus Biotherapeutics Corp (BRNS)|Kezar Life Sciences - Company Current Liabilities|Company Short-Term Loans and Borrowings SABS|Akari Therapeutics Plc - Company Short-Term Debts|Short-Term Debt Volume Enlivex Therapeutics ENLV|q32bio.com (QTTB) - Company Short-Term Debt|Company Current Liabilities GeoVax Corp|Company Short-Term Debt Edesa Biotech, Inc.|Company Current Liabilities ibioinc.com (IBIO)|Company Current Liabilities CARM (Carisma Therapeutics)|Company Short-Term Debts XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB: Company Short-Term Indebtedness|Aptevo - Company Short-Term Debts|Short-Term Debt aimimmuno.com|ADTX: Company Short-Term Debts|GRI Bio Inc (GRI) - Company Short-Term Debts|Company Short-Term Debt XORTX|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debts REVB|indaptusrx.com (INDP) - Short-Term Indebtedness|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|CalciMedica Inc (CALI) - Short-Term Debt|AFMD - Company Short-Term Debt|ALLK (Allakos Inc.) - Company Short-Term Indebtedness|HOOK (hookipapharma.com) - Company Current Liabilities|Company Short-Term Indebtedness IGMS|Company Current Liabilities ITOS|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Short-Term Debt Volume Third Harmonic Bio Inc